Back to Search
TYLER ATKINS M.D.
M.D.
Neurological Surgery Physician
NPI: 1114331493IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
201649(NC)01086221A(IN)
Education
OTHER
Class of 2014
Research & Publications (20)
Heating caused by selected pulsed Doppler and physiotherapy ultrasound beams measured using thermal test objects.
PMID 12573794·Eur J Ultrasound·2003
8-other
A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.
PMID 12183585·Infect Immun·2002
7-preclinical
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
PMID 19490962·Vaccine·2009
7-preclinical
Differential cell surface properties of vegetative Bacillus.
PMID 19187499·Lett Appl Microbiol·2009
7-preclinical
Burkholderia pseudomallei: animal models of infection.
PMID 19121670·Trans R Soc Trop Med Hyg·2008
7-preclinical
Polysaccharides and virulence of Burkholderia pseudomallei.
PMID 17644705·J Med Microbiol·2007
7-preclinical
Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
PMID 17517877·Infect Immun·2007
7-preclinical
The identification of surface proteins of Burkholderia pseudomallei.
PMID 17289218·Vaccine·2007
8-other
The pathogen Pseudomonas aeruginosa negatively affects the attraction response of the nematode Caenorhabditis elegans to bacteria.
PMID 16678995·Microb Pathog·2006
7-preclinical
Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence.
PMID 16801407·Antimicrob Agents Chemother·2006
8-other
Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.
PMID 16997946·J Bacteriol·2006
7-preclinical
A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins.
PMID 17041850·J Infect Dis·2006
7-preclinical
A type IV pilin, PilA, Contributes To Adherence of Burkholderia pseudomallei and virulence in vivo.
PMID 15664977·Infect Immun·2005
7-preclinical
The nematode Panagrellus redivivus is susceptible to killing by human pathogens at 37 degrees C.
PMID 16040202·FEMS Microbiol Lett·2005
4-observational
Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
PMID 15289563·Microbiology (Reading)·2004
7-preclinical
Age influences resistance of Caenorhabditis elegans to killing by pathogenic bacteria.
PMID 15135534·FEMS Microbiol Lett·2004
7-preclinical
Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis.
PMID 15585494·J Med Microbiol·2004
4-observational
Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei.
PMID 15377794·Proc Natl Acad Sci U S A·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1000 BLYTHE BLVD
CHARLOTTE, NC 28203 - Phone
- (704) 355-4823
Quick Facts
- NPI
- 1114331493
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile